Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A Single Phenotypic Biomarker of Gemtuzumab Ozogamicin (GO) Response in Acute Myeloid Leukemia Using Ex-Vivo Testing

Cintia Garro, Magali Ridano, Lía Buffa, Natalia Cavallo, Agustina Conrrero, Gimena Ferreira, Marisa Piaggio, Silvina Palmer, Blanca Rossi, Juan José García, Maria Sol Jarchum, Gustavo Jarchum, Tarek Ali Zaki, Gerardo Gatti, Candelaria Llorens, Gastón Soria

Blood (2023) 142 (Supplement 1): 5767.

https://doi.org/10.1182/blood-2023-180244

Published: 2023

Journal Articles

Identification of Unexpected Responders to Gilteritinib in a Cohort of FLT3-WT AML Patients Using Ex-Vivo Testing

Blood (2023) 142 (Supplement 1): 7132.

https://doi.org/10.1182/blood-2023-181119

Published: 2023

Journal Articles

Ex-Vivo Testing Platform to Predict Clinical Response and Resistance to Proteosome Inhibitors, IMiDs and Daratumumab in Multiple Myeloma

Constanza Marin, Maribel Nicola, Diego Andino, Maria Laura Bernaschini, Agustina Conrrero, Gimena Ferreira, Marisa Piaggio, Guillermina Remaggi, Maria Sol Jarchum, Gustavo Jarchum, Rodrigo Meneces Bustillo, Blanca de los Milagros Rossi, Juan José García, Tarek Ali Zaki, Candelaria Llorens, Gerardo Gatti, Daniela Arroyo, Gastón Soria

Blood (2023) 142 (Supplement 1): 5033.

https://doi.org/10.1182/blood-2023-185019

Published: 2023

Journal Articles

Ex-Vivo Testing Using Patient Micro Avatars (PMAs) Predicts Clinical Response in Acute Leukemias

Blood (2022) 140 (Supplement 1): 13027–13028.

https://doi.org/10.1182/blood-2022-164847

Published: 2022

Journal Articles

Multiple Myeloma Patients Aged 40 Years and Younger Have the Same Prognosis As Older Patients in an Analysis of Real-World Evidence from Latin America: A Study of 1,316 Patients from the Gelamm Latin American Multiple Myeloma Studygroup

Humberto Martinez-Cordero, Camila Peña, Natalia Paola Schutz, Virginia Bove, Fiorella Villano, Rocío Osorio, Mauricio Chandia, Cecilia Beltrán, Javier Schulz, Daniela Cardemil, Carolina Contreras, Carmen Gloria Vergara, Javiera Donoso, Marcela Espinoza, Gabriel La Rocca, Hernán López-Vidal, Pilar León, Macarena Roa, Christine Rojas, Pablo Soto, Sandra Aranda, Vivianne Torres, Paola Ochoa, Patricio Duarte, Guillermina Remaggi, Sebastian Yantorno, Ariel Corzo, Soledad Zabaljauregui, Claudia Shanley, Sergio Lopresti, Sergio Orlando, Veronica Verri, Luis Darío Quiroga, Juan Jose Garcia, Vanesa Fernandez, Dorotea Fantl, Jhoanna Ramirez, Alicia Molina, Pilar Papilco, Alex Mite, Ines Reyes, Brenner Sabando Vélez, Francisca M. Ramirez Aspiazu, Claudia Lucia Sossa, Virginia Abello, Henry Idrobo, Domingo Saavedra, Guillermo Quintero, Lina Gaviria, Rigoberto Gomez, Monica Osuna Pérez, Alicia Henao-Uribe, Luz del Carmen Tarín Arzaga, Omar Cantú-Martínez, David Gomez-Almaguer, Yarely Itzayana García-Navarrete, Antonio Cruz-Mora, Yahveth Cantero-Fortiz, Guillermo J. Ruiz-Arguelles, Eloisa Riva, Isabella Novoa-Caicedo

Blood (2022) 140 (Supplement 1): 7189–7191.

https://doi.org/10.1182/blood-2022-158104

Published: 2022

Journal Articles

Real World Outcomes in Latin-American Patients with Multiple Myeloma Under 40 Years Old

Humberto Martínez-Cordero, MD, Camila Peña, MD, Natalia Paola Schutz, MDMSc, Virginia Bove, MD, Fiorella Villano, MD, Rocío Osorio, MD, Mauricio Chandia, MD, Cecilia Beltran, MD, Javier Schulz, MD, Daniela Cardemil, MD, Carolina Contreras, MD, Carmen Gloria Vergara, MD, Javiera Donoso, MD, Marcela Espinoza, MD, Gabriel La Rocca, MD, Hernán López-Vidal, MD, Pilar León, MD, Macarena Alejandra Roa Salinas, Christine Rojas, MD, Pablo Soto, MD, Sandra Aranda, MD, Vivianne Torres, MD, Paola Ochoa, MD, Patricio Duarte, MD, Guillermina Remaggi, MD, Sebastian Yantorno, MD, Ariel Corzo, MD, Soledad Zabaljauregui, MD, Claudia Shanley, MD, Sergio Lopresti, MD, Sergio Orlando, MD, Veronica Verri, MD, Luis Darío Quiroga, MD, Juan Jose Garcia, MD, Vanesa Fernandez, MD, Dorotea Fantl, MD, Jhoanna Ramirez, MD, Alicia Molina, MD, Pilar Papilco, MD, Alex Mite, MD, Ines Reyes, MD, Brenner Sabando, Francisca M. Ramirez Aspiazu, MD, Claudia Lucia Sossa, MD, Virginia Abello, MD, Henry Idrobo, MD Professor, Domingo Saavedra, MD, Guillermo Quintero, MD MBA, Lina Gaviria, MD, Rigoberto Gomez, MD, Monica Osuna Pérez, MD, Alicia Henao-Uribe, MD, Luz del Carmen Tarín Arzaga, MD, Omar Cantú-Martínez, MD, David Gomez-Almaguer, MD, Yarely Itzayana García-Navarrete, MD, Antonio Cruz-Mora, MD, Yahveth Cantero-Fortiz, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Eloisa Riva, MD

Blood (2019) 134 (Supplement_1): 5508.

https://doi.org/10.1182/blood-2019-130987

Published: 2019

Journal Articles

Second Transplants for Relapsed Acute Leukemia: Real World Experience from Argentina

Lucia Antonella Bet, MD, Mariano Berro, MD, Maria Ines Paganini, Ana Basquiera, MD, Silvina Palmer, MD, Juan Jose Garcia, MD, Juan Jose Real, Juliana Martinez Rolon, MD, Martin Castro, Gustavo Kusminsky, MD

Blood (2018) 132 (Supplement 1): 5740.

https://doi.org/10.1182/blood-2018-99-119909

Published: 2018

Journal Articles

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Argentina: Results Comparing Matched Related, Unrelated or Haploidentical Donors. a Grupo Argentino De Trasplante De Medula Osea (GATMO) Experience

Jose Ignacio Ignacio Trucco, Mariano Berro, MD, Maria Marta Rivas, MD, Pablo Gabriel Longo, MD, Pablo Andres Garcia, MD, Juan Jose Garcia, MD, Ana Basquiera, MD, Gonzalo Ariel Ferini, MD, Sebastian Yantorno, MD, Jorge Milone, MD, Silvina Palmer, MD, German Stemmelin, MD, Alejandro Requejo, MD, Gregorio Jaimovich, MD, Adriana Vitriu, MD, Maria Cecilia Foncuberta, MD, Juliana Martinez Rolon, MD, Gustavo Kusminsky, MD

Blood (2017) 130 (Supplement 1): 5558.

https://doi.org/10.1182/blood.V130.Suppl_1.5558.5558

Published: 2017

Journal Articles

Comparison of Outcomes after Matched Sibling, Unrelated, or Haploidentical Allogeneic Hematopoietic Cell Transplantations (HCT). a Real World Experience of Gatmo (Grupo Argentino de Trasplante de Médula Ósea)

Jose Ignacio Ignacio Trucco, Mariano Berro, MD, Maria Marta Rivas, MD, Pablo Gabriel Longo, MD, Juan Jose Garcia, MD, Pablo Andres Garcia, MD, Ana Basquiera, MD, Gonzalo Ariel Ferini, MD, Sebastian Yantorno, MD, Jorge Milone, MD, Silvina Palmer, MD, German Stemmelin, MD, Alejandro Requejo, MD, Gregorio Jaimovich, MD, Adriana Vitriu, MD, Maria Cecilia Foncuberta, MD, Juliana Martinez Rolon, MD, Gustavo Kusminsky, MD

Blood (2017) 130 (Supplement 1): 2054.

https://doi.org/10.1182/blood.V130.Suppl_1.2054.2054

Published: 2017

Journal Articles

A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

Florencia Negri Aranguren, MD, Santiago Cranco, Claudia Shanley, MD, Isolda I. Fernandez, MD, Maria Virginia Prates, MD, Victoria Otero, Lorena Fiad, Maria Cecilia Foncuberta, MD, Marcela Miodosky, MD, Miguel A. Pavlovsky, MD, Gustavo Kuminsky, Javier Bordone, Bruno Wannesson, Ariel Corso Corso, Dardo Riveros, MD, Marisa Marquez, MD, Gustavo Jarchum, MD, Maria Sol Jarchum, Ider Ramon Cerutti, MD, Alicia Bistmas, Monica Tamashiro, MD, Giselda De Stefano, Alicia Navieckas, Silvana Cugliari, MD, Pedro Negri Aranguren, MD, Gabriela Balaguer, Maria Tosin, Guillermina Remaggi, Juan Altuve, Juan Jose Garcia, MD, Luciana C. Ferrari, MD, Graciela Klein, Luciana Guanchiale, Luis Beligoy, MD, Mariana Marull, Maria Cecilia Dacunto, Marta Elisa Zerga, MD, Nicolas Matias Kurgansky, MD, Marcelo Pujol, MD, Rossana L. Taus, MD PhD, Federico Sackman, MD PhD, Veronica Cintia Canosa, Soledad Cruset, Maximiliano Riddick, Astrid Pavlovsky, MD

Blood (2017) 130 (Supplement 1): 4089.

https://doi.org/10.1182/blood.V130.Suppl_1.4089.4089

Published: 2017

Journal Articles

Cytogenetic Response in Relation to the Adherence to Treatment with Imatinib Mesylate: A Case Control Study.

Carlos Doti, MD, German Stemmelin, MD, Claudia Shanley, MD, Jose Ceresetto, MD, Oscar Rabinovich, MD, Beatriz Moiraghi, MD, Maria Gabriela Flores, MD, Juan Jose Garcia, MD, Eduardo Bullorsky, MD

Blood (2007) 110 (11): 4553.

https://doi.org/10.1182/blood.V110.11.4553.4553

Published: 2007

Journal Articles

Subcutaneous Alemtuzumab in Patients with Refractory/Relapsed B-Cell CLL after a Fludarabine-Based Regimen. An Interim Analysis.

R. Fernando Bezares, German Stemmelin, Daniel Argentieri, Emilio Lanari, Efrain Guy-Garay, Reinaldo Campestri, Miguel Bartomioli, Juan Jose Garcia, Sergio Giralt, Gustav Milone, on Behalf of the Latin American Cooperative Onco-Hematology Group (LACOHG)

Blood (2006) 108 (11): 2843.

https://doi.org/10.1182/blood.V108.11.2843.2843

Published: 2006

NARROW

A Single Phenotypic Biomarker of Gemtuzumab Ozogamicin (GO) Response in Acute Myeloid Leukemia Using Ex-Vivo Testing

Identification of Unexpected Responders to Gilteritinib in a Cohort of FLT3-WT AML Patients Using Ex-Vivo Testing

Ex-Vivo Testing Platform to Predict Clinical Response and Resistance to Proteosome Inhibitors, IMiDs and Daratumumab in Multiple Myeloma

Ex-Vivo Testing Using Patient Micro Avatars (PMAs) Predicts Clinical Response in Acute Leukemias

Multiple Myeloma Patients Aged 40 Years and Younger Have the Same Prognosis As Older Patients in an Analysis of Real-World Evidence from Latin America: A Study of 1,316 Patients from the Gelamm Latin American Multiple Myeloma Studygroup

Real World Outcomes in Latin-American Patients with Multiple Myeloma Under 40 Years Old

Second Transplants for Relapsed Acute Leukemia: Real World Experience from Argentina

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Argentina: Results Comparing Matched Related, Unrelated or Haploidentical Donors. a Grupo Argentino De Trasplante De Medula Osea (GATMO) Experience

Comparison of Outcomes after Matched Sibling, Unrelated, or Haploidentical Allogeneic Hematopoietic Cell Transplantations (HCT). a Real World Experience of Gatmo (Grupo Argentino de Trasplante de Médula Ósea)

A Retrospective Multicenter Analysis of the Safety and Efficacy of Brentuximab Vedotin (BV) As Monotherapy or in Combination with Bendamustine (BV-B) in Relapsed Refractory Classic Hodgkin Lymphoma (cHL) in Argentina

Cytogenetic Response in Relation to the Adherence to Treatment with Imatinib Mesylate: A Case Control Study.

Subcutaneous Alemtuzumab in Patients with Refractory/Relapsed B-Cell CLL after a Fludarabine-Based Regimen. An Interim Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only